Company Filing History:
Years Active: 2014
Title: Michael Carsten Truβ: Innovator in Prostatic Disease Treatment
Introduction
Michael Carsten Truβ is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical treatments, particularly concerning prostatic diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Truβ holds a patent for the "Use of phosphodiesterase inhibitors in the treatment of prostatic diseases." This invention pertains to the use of inhibitors of phosphodiesterase I, IV, and V for the prophylaxis and treatment of prostatic diseases. His work aims to improve the quality of life for individuals suffering from these conditions.
Career Highlights
Throughout his career, Michael Carsten Truβ has been associated with Uropep Biotech GbR, a company focused on biotechnological advancements. His expertise in the field has allowed him to contribute significantly to the development of innovative treatments.
Collaborations
Truβ has collaborated with esteemed colleagues such as Wolf-Georg Forssmann and Christian Georg Stief. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Michael Carsten Truβ's contributions to the treatment of prostatic diseases through his innovative patent highlight his dedication to improving healthcare. His work continues to inspire advancements in medical technology and treatment options.